Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrincess Priv Regulatory News (PEYS)

Share Price Information for Princess Priv (PEYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 922.00
Bid: 888.00
Ask: 922.00
Change: 0.00 (0.00%)
Spread: 34.00 (3.829%)
Open: 922.00
High: 922.00
Low: 922.00
Prev. Close: 905.00
PEYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV increases by 0.2%

26 Jun 2018 07:00

RNS Number : 4865S
Princess Private Equity Holding Ltd
26 June 2018
 

News Release

Guernsey, 26 June 2018

 

NAV increases by 0.2%

 

· Princess Private Equity Holding Limited's (Princess) net asset value increased by 0.2% to EUR 11.04 per share

· Portfolio developments (0.1%) and currency movements (0.4%) were positive

· Princess received distributions of EUR 6.4 million and invested EUR 21.8 million over the reporting period

 

Princess received distributions of EUR 6.4 million during the month, including EUR 2.4 million in proceeds from the partial sale of shares in Black Knight Financial Services, a US-based provider of integrated technology, services, data and analytics to lenders and servicers in the mortgage and real estate industries. The remaining EUR 4.0 million of distributions came predominantly from Princess' mature legacy fund portfolio.

 

Princess invested a total of EUR 21.8 million during the month, of which EUR 17.8 million was invested in the previously announced investment Hearthside Food Solutions ("Hearthside") alongside Charlesbank Capital Partners. Hearthside is the largest independent bakery in the US and produces a broad range of high-quality nutrition bars, cookies, cereals and other baked foods and snacks for some of the world's premier food brands. Following the investment, Partners Group and Charlesbank will work closely with Hearthside's management team on a number of value creation initiatives. These will be focused on promoting organic growth by providing customers with an even wider range of innovative product solutions, executing select add-on acquisitions to further expand the business into adjacent industries and geographies, and optimizing existing manufacturing processes. EUR 1.6 million was invested in existing portfolio company Cerba HealthCare, a European medical laboratory services operator, to fund Cerba's acquisition of Bio7. Bio7, a leader in the French routine clinical pathology market, is considered an attractive acquisition for Cerba, given its scale and market position. This strategic investment is in line with Cerba's value creation plan to drive a France-focused M&A consolidation strategy.

 

Further information is available in the monthly report, which can be accessed via: http://www.princess-privateequity.net/financialreports.

 

Ends.

 

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group, a global private markets investment management firm with EUR 61.9 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Princess Private Equity Holding Limited:

princess@partnersgroup.com

www.princess-privateequity.net

 

Registered Number: 35241

 

LEI: 54930038LU8RDPFFVJ57

 

Investor relations contact

George Crowe

Phone: +44 (0)20 7575 2771

Email: george.crowe@partnersgroup.com

 

Media relations contact

Jenny Blinch

Phone: +44 207 575 2571

Email: jenny.blinch@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRUVRURWWANUAR
Date   Source Headline
8th Apr 20244:35 pmRNSPrincess publishes February NAV
2nd Apr 20245:15 pmRNSSale of SRS Distribution
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSPrincess 2023 annual results and webcast details
21st Mar 20243:17 pmRNSChanges to Board Composition
4th Mar 20247:00 amRNSNAV increases by 0.8% in January
15th Feb 20247:00 amRNSChanges to Board composition
5th Feb 20247:00 amRNSPrincess publishes December NAV
5th Feb 20247:00 amRNSSave the date for 2023 annual results announcement
1st Feb 20247:00 amRNSTotal Voting Rights
5th Jan 20247:00 amRNSPrincess publishes November NAV
2nd Jan 20247:00 amRNSTotal Voting Rights
8th Dec 20233:00 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSPrincess publishes October NAV
24th Nov 20232:05 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSPrincess Q3 2023 Updates
22nd Nov 202311:30 amRNSSale of Civica
1st Nov 20237:00 amRNSNAV increases by 0.9% in September
1st Nov 20237:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSChanges to Board Composition
27th Oct 20235:30 pmRNSDividend Declaration
23rd Oct 20237:00 amRNSSave the date for Q3 2023 results announcement
2nd Oct 20237:00 amRNSNAV increases by 0.6% in August
2nd Oct 20237:00 amRNSTotal Voting Rights
18th Sep 20237:15 amEQSJPMorgan European Discovery Trust: A balanced trust targeting a world-beating market
18th Sep 20237:00 amEQSUtilico Emerging Markets Trust: Emerging market growth opportunities at a discount
13th Sep 20237:00 amEQSMurray International Trust (MYI): Business as usual at Murray International
7th Sep 20237:15 amEQSEdison issues update on Princess Private Equity Holding (PEY)
1st Sep 20237:00 amRNSPrincess publishes July NAV
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202310:48 amRNSHolding(s) in Company
30th Aug 20239:40 amRNSHolding(s) in Company
24th Aug 20237:00 amRNSPrincess publishes Half-Year Report 2023
1st Aug 20239:55 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSPrincess publishes June NAV
25th Jul 20237:00 amRNSSave the date for Q2 2023 results announcement
4th Jul 20237:00 amRNSNAV increases by 2.0% in May
3rd Jul 20237:00 amRNSTotal Voting Rights
26th Jun 20233:00 pmRNSHolding(s) in Company
23rd Jun 202312:00 pmRNSResult of AGM
22nd Jun 20235:00 pmRNSWithdrawal of directors’ nominations for AGM
1st Jun 20237:00 amRNSPrincess publishes April NAV
1st Jun 20237:00 amRNSTotal Voting Rights
23rd May 20237:00 amRNSPrincess Q1 2023 results presentation
19th May 20235:03 pmRNSHolding(s) in Company
19th May 20237:00 amRNSNotice of Annual General Meeting
2nd May 20237:00 amRNSNAV increases by 0.3% in March
2nd May 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.